comparemela.com

Latest Breaking News On - German private equity - Page 1 : comparemela.com

Hong Kong: FS visits German businesses in Berlin

A new kind of PE fund plans to roll-up German startups into potential unicorns and bigger exits

German private equity investor FLEX Capital (based out of Berlin) says it has now closed its second fund of €300 million with the aim of effectively rolling-up medium-sized German- speaking tech companies and giving these merged entities greater global scale. This is an unusual use of PE funds, and puts FLEX into a slightly different category to the average PE outfit.

XClinical to Merge with Carenity and Fortress Medical Systems Forming a New Data Science Company Serving Life Science Markets Worldwide

Posted on 311 XClinical, a leading vendor of eClinical software has announced a merger with France-based Carenity, a social platform supporting patients and caregivers worldwide, and Fortress Medical Systems, the US-based vendor of Clindex®, an integrated CTMS and EDC system. All three companies are long-established, leading providers in their respective markets. The group is financed by German Private Equity firm BID Equity. Together, the three businesses will form a new, innovative data science company, powered by cutting edge technology. The group brings best in class data science and eClinical software solutions together, delivering end-to-end coverage of the clinical development process for their 150+ customers in over 20 countries, including US, Germany, France, UK, Italy, Japan and China.

XClinical GmbH: XClinical to Merge with Carenity and Fortress Medical Systems Forming a New Data Science Company Serving Life Science Markets Worldwide

(0) XClinical, a leading vendor of eClinical software has announced a merger with France-based Carenity, a social platform supporting patients and caregivers worldwide, and Fortress Medical Systems, the US-based vendor of Clindex, an integrated CTMS and EDC system. All three companies are long-established, leading providers in their respective markets. The group is financed by German Private Equity firm BID Equity. Together, the three businesses will form a new, innovative data science company, powered by cutting edge technology. The group brings best in class data science and eClinical software solutions together, delivering end-to-end coverage of the clinical development process for their 150+ customers in over 20 countries, including US, Germany, France, UK, Italy, Japan and China.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.